Brazil government partnership confirms BMJ Group’s healthy international growth

The BMJ Group has agreed a major new partnership with the Ministry of Health in Brazil to provide its evidence based clinical decision support tool Best Practice to 350,000 clinicians across the country.

The partnership has been agreed in conjunction with international distributor, Dotlib and CAPES, the government arm responsible for graduate education in Brazil.

Key government initiatives to promote health and quality of life in Brazil include integrating emergency care services, improving access to low-cost essential medicines, and expanding family health networks to tackle public health issues. The partnership with the BMJ Group will help support the government’s drive for quality improvement and better outcomes for patients.

Doctors across Brazil will now be provided with the latest evidence, expert opinion, and guidelines. This will help clinicians to make more informed and faster diagnostic and treatment decisions for their patients.

This multi-million dollar investment is the latest national licence for the BMJ Group’s Clinical Improvement Division and the first in Latin America. It further establishes the Group as a global player in the clinical decision support (CDS) space, and illustrates the Group’s growing capabilities to support governments and enable health systems to drive fundamental change.

The BMJ Group has continued to flourish, particularly in international markets - securing major partnerships in the US, India, China and right across Europe and the Middle East over the last 12 months. Its successful globalisation strategy has resulted in significant investment in local business hubs in the US and India, and there are imminent plans to expand further into China, the Middle East and Brazil.

As a result of this international expansion, the BMJ Group’s business has doubled in the last six years with over half of revenue coming from international activities.

Stella Dutton, CEO of the BMJ Group said: “This is further validation of the Group’s broadening capabilities. We are delighted to support the government’s initiatives and confident that this marks the beginning of a long-term relationship with the Ministry of Health in Brazil.”

She added: “The BMJ Group continues to go from strength to strength, driven by a growing international reputation as a leading provider of trusted evidence-based support for healthcare professionals, researchers and patients.

Today’s announcement builds on this success and we are justly proud of that. It also lays the foundation for dialogue with other government health departments around the world. It’s a truly exciting time for the BMJ Group and I look forward to seeing what the future holds.”